IDEAYA Biosciences, Inc.
IDYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -70.1% | -54.1% | 82.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.2% | 82.9% | 95.9% | 93.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,866.3% | -465.9% | -111% | -171.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,921.1% | -483% | -115.2% | -178.1% |
| EPS Diluted | -3.36 | -1.96 | -1.42 | -1.41 |
| % Growth | -71.4% | -38% | -0.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |